-
Oklahoma was one of the first states to successfully sue drugmakers for their role in the opioid epidemic, but almost none of that money has been spent so far. A bill moving through the legislature could change that.
-
The Sacklers, who own Purdue Pharma, maker of Oxycontin, have maintained they did nothing wrong. People who lost loved ones and years of their lives to opioid addiction believe otherwise.
-
The deal, hashed out over weeks of intense negotiations, raises the amount paid by the Sacklers by more than $1 billion. In exchange, the family members win immunity from civil opioid lawsuits.
-
Companies at the center of the deadly prescription opioid epidemic are close to deals that would cap their liability while funding drug treatment and recovery programs.
-
The lawsuit brought by more than 100 tribal nations will benefit all 574 federally recognized tribes.
-
Johnson & Johnson, AmerisourceBergen, McKesson and Cardinal Health will pay $590 million to Native American tribes under a proposed settlement for the companies' role in the opioid crisis.
-
The pharmacy says it will bypass health care industry "middlemen" and help consumers avoid high drug prices by charging manufacturers' prices plus a flat 15% markup and pharmacist fee.
-
Martin Shkreli, who is serving a seven-year prison sentence for fraud, must return profits he and his former company reaped from raising the price of a lifesaving drug, a federal judge ruled.
-
A separate trial will follow to determine what Teva will have to pay in the case, in which New York state and two Long Island counties took on a swath of drug companies.
-
The roughly $2 trillion House-passed measure awaits Senate action. The Senate majority leader says he'd like to try to finish by Christmas.